(1S,5R,13R,14S,17R)-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol hydrochloride

• ChemBase编号: 174925
• 分子式: C19H22ClNO3
• 平均质量: 347.83588
• 单一同位素质量: 347.12882125
• SMILES: c1(c2c3c(cc1)C[C@@H]1[C@H]4[C@@]3([C@H]([C@H](C=C4)O)O2)CCN1CC=C)O.Cl
• Canonical SMILES: C=CCN1CC[C@@]23[C@@H]4[C@H]1Cc1c3c(O[C@H]2[C@H](C=C4)O)c(cc1)O.Cl
• InChI: InChI=1S/C19H21NO3.ClH/c1-2-8-20-9-7-19-12-4-6-15(22)18(19)23-17-14(21)5-3-11(16(17)19)10-13(12)20;/h2-6,12-13,15,18,21-22H,1,7-10H2;1H/t12-,13+,15-,18-,19-;/m0./s1
• InChIKey: NAHATSPWSULUAA-ZQGPYOJVSA-N

名称和登记号

名称

• IUPAC标准名: (1S,5R,13R,14S,17R)-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0^1,^1^3.0^5,^1^7.0^7,^1^8]octadeca-7(18),8,10,15-tetraene-10,14-diol hydrochloride
• IUPAC传统名: nalorphine hydrochloride
• 别名: (5α,6α)-7,8-Didehydro-4,5-epoxy-17-(2-propen-1-yl)morphinan-3,6-diol Hydrochloride; 17-Allyl-7,8-didehydro-4,5α-epoxymorphinan-3,6α-diol Hydrochloride; N-Allylnormorphine Hydrochloride; NIH 10124; Naline Hydrochloride; Nalorphine Chloride; Nalorphine Hydrochloride

登记号

• CAS号: 57-29-4
• PubChem SID: 164230835
• PubChem CID: 5484366

理论计算性质

• Acid pKa: 10.204004
• 质子受体: 4
• 质子供体: 2
• LogD (pH = 5.5): -1.1795136
• LogD (pH = 7.4): 0.48296607
• Log P: 1.6752604
• 摩尔折射率: 89.2851 cm^3
• 极化性: 34.137146 Å^3
• 极化表面积: 52.93 Å^2
• 可自由旋转的化学键: 2
• 里宾斯基五规则: true

分子性质

安全信息

• 保存条件: Controlled Substance, -20°C Freezer

详细说明

Toronto Research Chemicals - N284450

Narcotic antagonist.Controlled substance.

参考文献

• McCawley, H., et al.: J. Pharmacol., 82, 339 (1944)
• Goldenthal, E.I., et al.: Toxicol. Appl. Pharmacol., 18, 185 (1944)
• Zubair, M.U., et al.: Anal. Profiles Drug Subs., 18, 195 (1944)